Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yujin Hoshida

Showing results (91-100 of 263) with videos related to

Pageof 27
Sort By:
Journal of Gastroenterology|February 8, 2003
Identification of genes associated with sensitivity to 5-fluorouracil and cisplatin in hepatoma cellsYujin Hoshida, Masaru Moriyama, Motoyuki Otsuka, et al.
Gastroenterology|September 10, 2013
Genome-wide methylation analysis and epigenetic unmasking identify tumor suppressor genes in hepatocellular carcinomaKate Revill, Tim Wang, Anja Lachenmayer, et al.
Frontiers in Genetics|October 18, 2019
MPIC: Molecular Prognostic Indicators in Cirrhosis Database for Clinical Context-Specific <i>in Silico</i> Prognostic Biomarker ValidationShun H Yip, Naoto Fujiwara, Jason Burke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 21, 2017
Patient-derived Interstitial Fluids and Predisposition to Aggressive Sporadic Breast Cancer through Collagen Remodeling and Inactivation of p53Timothy C Kenny, Hank Schmidt, Kerin Adelson, et al.
Experimental & Molecular Medicine|January 6, 2018
In vitro modeling of hepatocellular carcinoma molecular subtypes for anti-cancer drug assessmentHadassa Hirschfield, C Billie Bian, Takaaki Higashi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 1, 2019
Gene signature-MELD score and alcohol relapse determine long-term prognosis of patients with severe alcoholic hepatitisPierre Deltenre, Eric Trépo, Naoto Fujiwara, et al.
Hepatology International|October 21, 2023
Fibroblast growth factor inhibition by molecular-targeted agents mitigates immunosuppressive tissue microenvironment in hepatocellular carcinomaHiroyuki Suzuki, Hideki Iwamoto, Toshimitsu Tanaka, et al.
Pharmacogenomics|June 4, 2020
Brazilian cohort and genes encoding for drug-metabolizing enzymes and drug transportersVera Kim, Thijs van der Wal, Miriam Yumie Nishi, et al.
Molecular Cancer Therapeutics|February 18, 2003
Relevance network between chemosensitivity and transcriptome in human hepatoma cellsMasaru Moriyama, Yujin Hoshida, Motoyuki Otsuka, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 17, 2021
A Blood-Based Prognostic Liver Secretome Signature Predicts Long-term Risk of Hepatic Decompensation in CirrhosisNaoto Fujiwara, Austin J Fobar, Indu Raman, et al.
Pageof 27

Showing results (91-100 of 263) with videos related to

Sort By:
Pageof 27
Journal of Gastroenterology|February 8, 2003
Identification of genes associated with sensitivity to 5-fluorouracil and cisplatin in hepatoma cellsYujin Hoshida, Masaru Moriyama, Motoyuki Otsuka, et al.
Gastroenterology|September 10, 2013
Genome-wide methylation analysis and epigenetic unmasking identify tumor suppressor genes in hepatocellular carcinomaKate Revill, Tim Wang, Anja Lachenmayer, et al.
Frontiers in Genetics|October 18, 2019
MPIC: Molecular Prognostic Indicators in Cirrhosis Database for Clinical Context-Specific <i>in Silico</i> Prognostic Biomarker ValidationShun H Yip, Naoto Fujiwara, Jason Burke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 21, 2017
Patient-derived Interstitial Fluids and Predisposition to Aggressive Sporadic Breast Cancer through Collagen Remodeling and Inactivation of p53Timothy C Kenny, Hank Schmidt, Kerin Adelson, et al.
Experimental & Molecular Medicine|January 6, 2018
In vitro modeling of hepatocellular carcinoma molecular subtypes for anti-cancer drug assessmentHadassa Hirschfield, C Billie Bian, Takaaki Higashi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 1, 2019
Gene signature-MELD score and alcohol relapse determine long-term prognosis of patients with severe alcoholic hepatitisPierre Deltenre, Eric Trépo, Naoto Fujiwara, et al.
Hepatology International|October 21, 2023
Fibroblast growth factor inhibition by molecular-targeted agents mitigates immunosuppressive tissue microenvironment in hepatocellular carcinomaHiroyuki Suzuki, Hideki Iwamoto, Toshimitsu Tanaka, et al.
Pharmacogenomics|June 4, 2020
Brazilian cohort and genes encoding for drug-metabolizing enzymes and drug transportersVera Kim, Thijs van der Wal, Miriam Yumie Nishi, et al.
Molecular Cancer Therapeutics|February 18, 2003
Relevance network between chemosensitivity and transcriptome in human hepatoma cellsMasaru Moriyama, Yujin Hoshida, Motoyuki Otsuka, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 17, 2021
A Blood-Based Prognostic Liver Secretome Signature Predicts Long-term Risk of Hepatic Decompensation in CirrhosisNaoto Fujiwara, Austin J Fobar, Indu Raman, et al.
Pageof 27